Diagnosing fetal chromosomal aneuploidy using genomic sequencing
AssigneeThe Chinese University of Hong Kong
InventorsYuk-Ming Dennis Lo, Rossa Wai Kwun Chiu, Kwan Chee Chan
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Chinese University of Hong Kong
InventorsYuk-Ming Dennis Lo, Rossa Wai Kwun Chiu, Kwan Chee Chan
Estimating the term…
Embodiments of this invention provide methods, systems, and apparatus for determining whether a fetal chromosomal aneuploidy exists from a biological sample obtained from a pregnant female. Nucleic acid molecules of the biological sample are sequenced, such that a fraction of the genome is sequenced. Respective amounts of a clinically-relevant chromosome and of background chromosomes are determined from results of the sequencing. The determination of the relative amounts may count sequences of only certain length. A parameter derived from these amounts (e.g. a ratio) is compared to one or more cutoff values, thereby determining a classification of whether a fetal chromosomal aneuploidy exists. Prior to sequencing, the biological sample may be enriched for DNA fragments of a particular sizes.
A method for determining presence or absence of fetal aneuploidy in a fetus by analyzing a biological sample from a female pregnant with the fetus, the biological sample comprising a mixture of fetal DNA from the genome of the fetus and DNA from the genome of the pregnant female, wherein the method comprises:
A computer program product comprising a computer readable medium encoded with a plurality of instructions for controlling a computing system to perform an operation for determining presence or absence of fetal aneuploidy in a fetus by analyzing a biological sample from a female pregnant with the fetus, the biological sample comprising a mixture of fetal DNA from the genome of the fetus and DNA from the genome of the pregnant female, the instructions comprising:
Dependencies are inferred from the claim text.